Clinical Trials Logo

Carcinoma, Ductal clinical trials

View clinical trials related to Carcinoma, Ductal.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03523299 Enrolling by invitation - Clinical trials for Invasive Ductal Carcinoma, Breast

Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer

Start date: May 22, 2018
Phase: N/A
Study type: Interventional

This study will investigate the safety, feasibility, and immune response associated with cryoablation of early invasive breast cancer prior to lumpectomy. Based on mouse models, the investigators believe that cryoablation will initiate a stronger immune response relative to the control group. Consenting patients will be randomized to one of two arms: standard of care (control) or cryoablation (intervention). Participants will undergo a blood draw at the time of consent. Those in the control arm will continue with their standard of care lumpectomy. The intervention arm will receive cryoablation 2 weeks before their scheduled lumpectomy and undergo a second blood draw before the lumpectomy.